Concepedia

Kyle Glover

KG

Statistics

Publications

17

Citations

2.7K

H-Index

15

Active since

2009

Affiliations

DuPont (United States)(Current)

U.S. Army Combat Capabilities Development Command Chemical Biological Center

United States Army Medical Research and Development Command

Defense Threat Reduction Agency

Telemedicine & Advanced Technology Research Center

Kyle Glover is an author at DuPont (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

2009–2023

17

Publications

17

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 234 citations · Full text

, , +18

1–5 of 17